Scleroderma
164
24
28
87
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
24 trials with published results (15%)
Research Maturity
87 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.5%
14 terminated out of 164 trials
86.1%
-0.4% vs benchmark
9%
14 trials in Phase 3/4
28%
24 of 87 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 87 completed trials
Clinical Trials (164)
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Platform Clinical Study for Conquering Scleroderma
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
TENS in Scleroderma
Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs)
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
Personalized Online Occupational Therapy Intervention for Adults With Scleroderma
Skeletal Muscle Function in Interstitial Lung Disease
Brentuximab Vedotin for Systemic Sclerosis
MRI for Screening and Monitoring Scleroderma ILD
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
Hyaluronidase Via LADD Scleroderma-induced Microstomia
Pregnancy and Medically Assisted Conception in Rare Diseases